Klaas v The State

On 11 June 2009, police officers conducted a warrantless search at a house owned by the applicant (Michael Klaas, a retired pharmacologist) in Morningside, Johannesburg. The applicant was not present; his adult son, three-year-old son and domestic worker were found there. The police seized 2,920 tablets of methaqualone and methamphetamine, chemicals, equipment used in drug manufacturing, a chemistry book with handwritten formulas for manufacturing methaqualone, and other drug manufacturing equipment. The applicant's son and nephew were immediately arrested, but the applicant was arrested months later in East London. DNA evidence linked the applicant to gloves found at the scene, and handwriting analysis linked him to the manufacturing instructions. Evidence showed he had purchased chemicals from Glass World. The applicant was convicted on 22 November 2013 of unlawfully manufacturing drugs (count 1) and dealing in drugs (count 2) under section 5(b) of the Drugs and Drug Trafficking Act. On 10 December 2013, he was sentenced to 5 years' imprisonment on count 1 and 15 years' on count 2, to run concurrently. The applicant's defence was complete denial of knowledge, claiming he did not reside at the property but only visited occasionally, and that his nephew and domestic worker occupied the house with his minor son.

• Whether the applicant's right to privacy under section 14 of the Constitution was infringed by a warrantless search in his absence
• Whether the conviction based on circumstantial evidence was proper
• Whether the applicant received a fair trial in respect of sentencing under section 35(3)(o) of the Constitution
• Whether the minimum sentencing provisions under section 51(2) of the Criminal Law Amendment Act 105 of 1997 were properly applied
• Whether the State proved the market value of the drugs as required for minimum sentencing to apply
• What is the appropriate sentence given that minimum sentencing provisions were improperly invoked

1. Applications for condonation granted. 2. Leave to appeal against conviction refused. 3. Leave to appeal against sentence granted. 4. Appeal against sentence succeeds. 5. Orders of Supreme Court of Appeal and High Court dismissing appeal against sentence set aside. 6. Sentence of 15 years' imprisonment on count 2 set aside. 7. Applicant sentenced to 12 years' imprisonment on count 2. 8. Sentence on count 1 to run concurrently with sentence on count 2. 9. Sentence antedated to 10 December 2013.

For minimum sentencing provisions under Part II of Schedule 2 of the Criminal Law Amendment Act to apply to drug offences, the State must prove the market value of the drugs exceeded the threshold amount (R50,000) at the conviction stage, not merely the sentencing stage. "Value" in the minimum sentencing legislation means market value - the price a willing buyer pays a willing seller in an open market - and not an estimate, notional value, or potential value. An estimate of value by a police officer without expert evidence is insufficient to satisfy this jurisdictional requirement. Failure to prove market value before conviction means the jurisdictional fact entitling the court to impose the minimum sentence is absent, constituting a misdirection that entitles an appellate court to interfere with sentence and reconsider it afresh. When minimum sentencing provisions do not apply, courts retain discretion under section 17(e) of the Drugs and Drug Trafficking Act to impose appropriate sentences up to 25 years' imprisonment for drug manufacturing and dealing offences, considering the quantity of drugs, the nature of the offence, personal circumstances, and the need to protect society.

The Court made several non-binding observations: (1) The warrantless search conducted in 2009 was lawful under the then-applicable provisions of the Drugs Act and Criminal Procedure Act, and the subsequent declaration of unconstitutionality in Minister of Police v Kunjana [2016] ZACC 21 was not retrospective and did not apply to this case. (2) Sentenced prisoners experience difficulties when attempting to lodge applications timeously, which is a relevant factor in considering condonation applications. (3) The Court noted that "very serious sentences...should...generally and sparingly be reserved for drug manufacturers, suppliers and repeat offenders" (citing Mandlozi v S). (4) The Court observed that the quantity of drugs "directly corresponded to the number of lives potentially affected by the drug" and this consideration alone can outweigh personal circumstances of an accused. (5) In drug cases, "the interest of society demands a harsh sentence in order to be protected" from the impact of drug dealing (citing Umeh v S). (6) The Court commented that an applicant's advanced age is a relevant factor in determining whether sentences should run concurrently or consecutively. (7) The Court noted the applicant "exposed his minor son to the hazardous chemicals" as an aggravating factor, and that "only a sentence of long term imprisonment is called for" in serious drug manufacturing and dealing cases involving substantial quantities.

This case is significant in South African criminal law for clarifying the procedural requirements for invoking minimum sentencing provisions under the Criminal Law Amendment Act in drug-related offences. The judgment reinforces the principle established in S v Legoa that the State must prove the market value (not weight or estimate) of drugs at the conviction stage, not the sentencing stage, for minimum sentencing legislation to apply. The case demonstrates that failure to prove this jurisdictional fact constitutes an irregularity entitling appellate courts to interfere with sentence. The judgment also provides guidance on appropriate sentencing for drug manufacturing and dealing offences where minimum sentencing provisions do not apply, emphasizing that the quantity of drugs relates directly to the number of lives potentially affected and that long custodial sentences are appropriate even for first offenders involved in manufacturing. The case illustrates the Constitutional Court's commitment to fair trial rights, particularly regarding procedural fairness at the sentencing stage, while also recognizing the serious societal impact of drug offences.